Share-based Payment Arrangement, Expense in USD of SPRUCE BIOSCIENCES, INC. from Q3 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Spruce Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2019 to Q3 2025.
  • Spruce Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $415K, a 63.6% decline year-over-year.
  • Spruce Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $1.84M, a 67.1% decline year-over-year.
  • Spruce Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $5.35M, a 15.7% increase from 2023.
  • Spruce Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $4.62M, a 27.3% increase from 2022.
  • Spruce Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $3.63M, a 8.26% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

SPRUCE BIOSCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.84M $415K -$725K -63.6% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $2.57M -$77K -$1.76M -105% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-14
Q1 2025 $4.33M $544K -$1.02M -65.2% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 $5.35M $961K -$260K -21.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-15
Q3 2024 $5.61M $1.14M +$18K +1.6% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $5.59M $1.69M +$466K +38.2% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-14
Q1 2024 $5.12M $1.56M +$502K +47.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 $4.62M $1.22M +$419K +52.2% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-15
Q3 2023 $4.2M $1.12M +$339K +43.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $3.86M $1.22M +$314K +34.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $3.55M $1.06M -$81K -7.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $3.63M $802K +$5K +0.63% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-18
Q3 2022 $3.63M $783K -$248K -24.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $3.87M $905K -$105K -10.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $3.98M $1.14M +$21K +1.88% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $3.96M $797K +$388K +94.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $3.57M $1.03M +$813K +373% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $2.76M $1.01M +$914K +952% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.84M $1.12M +$1.09M +3400% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $755K $409K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 $218K +$156K +252% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $96K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $32K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q3 2019 $62K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-18

SPRUCE BIOSCIENCES, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $5.35M +$726K +15.7% Jan 1, 2024 Dec 31, 2024 10-K 2025-04-15
2023 $4.62M +$991K +27.3% Jan 1, 2023 Dec 31, 2023 10-K 2025-04-15
2022 $3.63M -$327K -8.26% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2021 $3.96M +$3.2M +424% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $755K +$559K +285% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-14
2019 $196K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.